SCHEMBL25334253

SCHEMBL25334253

O=[N+]([O-])c1cc(Br)c(F)cc1NC1CC1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 8/20 0.51
GAA P10253 2/20 0.51
GLA P06280 1/20 0.51
HCAR3 P49019 3/20 0.50
MEN1 O00255 3/20 0.49
KMT2A Q03164 3/20 0.49
L3MBTL1 Q9Y468 1/20 0.49
MAPK1 P28482 4/20 0.47
CYP1A2 P05177 1/20 0.44
CYP2C9 P11712 1/20 0.44
CYP2C19 P33261 1/20 0.44
HTT P42858 1/20 0.44
WNK1 Q9H4A3 2/20 0.43
POLB P06746 1/20 0.41
ALDH1A1 P00352 3/20 0.40
LMNA P02545 2/20 0.40
PKM P14618 1/20 0.38
TP53 P04637 1/20 0.38
ATM Q13315 1/20 0.38
TDP1 Q9NUW8 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31701891 0.94 MAPT (0.51) MAPTGAAGLAHCAR3MEN1
SCHEMBL29525723 0.87 MAPT (0.56) MAPTGAAGLAHCAR3MEN1
SCHEMBL17896593 0.87 MAPT (0.56) MAPTGAAGLAHCAR3MEN1
SCHEMBL28737547 0.86 MAPT (0.55) MAPTGAAGLAHCAR3MEN1
SCHEMBL28995708 0.82 MAPT (0.51) MAPTGAAGLAHCAR3MEN1
SCHEMBL20338334 0.81 MEN1 (0.58) MAPTGAAGLAHCAR3MEN1
SCHEMBL22724889 0.81 MEN1 (0.40) MAPTGAAGLAHCAR3MEN1
SCHEMBL2217900 0.79 MAPT (0.51) MAPTGAAGLAHCAR3MEN1
SCHEMBL4907442 0.78 IRAK4 (0.44) MAPTGAAGLAHCAR3MEN1
SCHEMBL27076021 0.78 HCAR3 (0.44) MAPTHCAR3KMT2AMAPK1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250152564-A1 PROPYLENE KETONE-CONTAINING BIOINHIBITOR, PREPARATION METHOD THEREFOR, AND USE THEREOF JIANGSU HANSOH PHARMACEUTICAL GROUP CO., LTD. (CN) 2025-05-15 US disclosed
CN-118574831-A Biological inhibitor containing acrylketone, preparation method and application thereof 上海翰森生物医药科技有限公司 2024-08-30 CN disclosed
WO-2023143514-A1 PROPYLENE KETONE-CONTAINING BIOINHIBITOR, PREPARATION METHOD THEREFOR, AND USE THEREOF 上海翰森生物医药科技有限公司 2023-08-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250152564-A1 PROPYLENE KETONE-CONTAINING BIOINHIBITOR, PREPARATION METHOD THEREFOR, AND USE THEREOF CYP51A1, HSD17B7, CYP46A1 MAPT 4016/4885GAA 3369/4885GLA 3831/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.